EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Cell‐based therapies for the treatment of rheumatoid arthritis

Maryam Zare Moghaddam iD, Mohammad Javad Mousavi, Somayeh Ghotloo

Immunity, Inflammation and Disease · 2023-11 · 11 (11)

DOI: 10.1002/iid3.1091 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Immunity, Inflammation and Disease, online erschienen am 22.11.2023. Verfasst von Maryam Zare Moghaddam und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, Shahid Sadoughi University of Medical Sciences, Yazd, Iran. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid, Autoimmune Diseases, Mesenchymal Stem Cells. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 183 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Autoimmune diseases, including rheumatoid arthritis that is the most prevalent rheumatic autoimmune disorder, affect autologous connective tissues caused by the breakdown of the self‐tolerance mechanisms of the immune system. During the last two decades, cell‐based therapy, including stem cells and none‐stem cells has been increasingly considered as a therapeutic option in various diseases. This is partly due to the unique properties of stem cells that divide and differentiate from the specialized cells in the damaged tissue. Moreover, stem cells and none‐stem cells, impose immunomodulatory properties affecting the diseases caused by immunological abnormalities such as rheumatic autoimmune disorders. In the present review, the efficacy of cell‐based therapy with four main types of stem cells, including mesenchymal stem cells, hematopoietic stem cells, embryonic stem cells, and human amniotic membrane cells, as well as none‐stem cells, including regulatory T cells, chimeric antigen receptor T cells, and tolerogenic dendritic cells will be evaluated. Moreover, other related issues, including safety, changes in immunological parameters, suitable choice of stem cell and none‐stem cell origin, conditioning regimen, limitations, and complications will be discussed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Arthritis, RheumatoidAutoimmune DiseasesMesenchymal Stem CellsHumansImmune ToleranceImmunomodulation

Stichwörter der Autor:innen

none-stem cellrheumatoid arthritisstem celltherapy

Autor:innen und Institutionen

  • Department of Immunology, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
  • Department of Hematology, Faculty of Allied Medicine, Bushehr University of Medical Sciences, Bushehr, Iran.
  • Autoimmune Diseases Research Center, Kashan University of Medical Sciences, Kashan, Iran.
  • Department of Clinical Laboratory Sciences, Kashan University of Medical Sciences, Kashan, Iran.

ORCID-Profile: Maryam Zare Moghaddam

Zitieren

APA

Moghaddam, M. Z., Mousavi, M. J., & Ghotloo, S. (2023). Cell‐based therapies for the treatment of rheumatoid arthritis. Immunity, Inflammation and Disease, 11(11). https://doi.org/10.1002/iid3.1091

Vancouver

Moghaddam MZ, Mousavi MJ, Ghotloo S. Cell‐based therapies for the treatment of rheumatoid arthritis. Immunity, Inflammation and Disease. 2023;11(11). doi:10.1002/iid3.1091

BibTeX
@article{Moghaddam2023,
  author = {Moghaddam, Maryam Zare and Mousavi, Mohammad Javad and Ghotloo, Somayeh},
  title = {Cell‐based therapies for the treatment of rheumatoid arthritis},
  journal = {Immunity, Inflammation and Disease},
  year = {2023},
  volume = {11},
  number = {11},
  doi = {10.1002/iid3.1091}
}
Kostenlos starten →